Vext Science Inc. reports developments for a U.S.-based cannabis operator with vertical operations in Arizona and Ohio. The company owns and operates cultivation facilities, manufacturing assets and dispensaries, and manufactures the Vapen brand of THC concentrates, edibles and distillate cartridges in Arizona.
Recurring news includes quarterly and annual financial results, operating cash flow and EBITDA updates, Ohio retail scaling, Arizona cultivation and manufacturing footprint decisions, and cannabis market activity across its core states. Company updates also cover shareholder meeting results, ownership disclosures, capital-structure matters involving multiple voting and subordinate voting shares, and trading references for its CSE-listed shares and OTCQX symbol VEXTF.
Vext Science (VEXTF) announced that Ohio regulators lifted all sale restrictions on its Vapen-branded products on October 14, 2026.
The Ohio Division of Cannabis Control had placed the products on administrative hold on September 8, 2026, based on two reported adverse health events. The agency released the hold based on testing data and analysis. Vapen products are being restocked across Vext's Ohio dispensaries and are again available to wholesale customers. All Ohio retail locations are fully open, and all product lines authorized for sale in Ohio are fully available.
Vext Science (VEXTF) has reopened its Herbal Wellness Center dispensary in Jackson, Ohio, on September 17, 2026, after receiving authorization from the Ohio Division of Cannabis Control and has agreed to restructure seller notes tied to its 2023 Ohio acquisitions.
The Jackson Dispensary has resumed service to patients and customers, with the company emphasizing health, safety and compliant access to cannabis products. The APP Notes, originally about US$6.0 million with a balloon payment of roughly US$5.6 million due December 31, 2026, will be modified so that approximately US$2.4 million is paid in cash on the first business day of January 2027, fully repaying four noteholders and partially repaying others. The remaining US$3.2 million will be replaced with new promissory notes bearing 8.0% interest until December 31, 2026 and 10.0% thereafter, amortized via equal monthly payments of about US$147,000 from February 15, 2027 to a final payment on January 15, 2029. The restructuring is expected to become effective October 1, 2026, subject to conditions.
Vext Science (VEXTF) has temporarily closed its Jackson, Ohio cannabis dispensary at the Ohio regulator's request pending an investigation. The company is cooperating, providing product samples for independent testing and quarantining certain product lines in Ohio, while its five other Ohio dispensaries and cultivation facility continue operating.
Vext Science (OTCQX: VEXTF) reported Q2 2026 sales of $12.1 million, roughly flat versus Q1 2026 but below Q2 2025, as Ohio growth offset the planned wind-down of Arizona cultivation and wholesale. Adjusted EBITDA rose 22% sequentially to $3.4 million, with a 28.3% margin, while net loss narrowed year-over-year to $(0.3) million. Operating cash flow was $1.2 million, reflecting an intentional Ohio inventory build.
The Company opened its sixth Ohio dispensary in Fairfield, completed the Arizona cultivation wind-down, and is marketing the Eloy property for sale, with proceeds expected to reduce secured debt. Subsequent to quarter-end, Vext extended a bank note to January 15, 2028 and closed $17.0 million in real estate financing with Wright-Patt Credit Union, refinancing existing debt, funding Ohio expansion, and acquiring full ownership of its Jackson, Ohio cultivation/manufacturing property. The Company also refined its non-IFRS Adjusted EBITDA reconciliations and increased its uncertain tax position liability to $11.7 million.
Vext Science (CSE: VEXT, OTCQX: VEXTF) plans to release its financial results for the quarter ended June 30, 2026, after market close on Thursday, August 20, 2026. The company will host a conference call and webcast the same day at 5:00 pm ET to discuss Q2 2026 results.
Vext (OTCQX: VEXTF) opened its sixth Ohio dispensary in Fairfield, a northern Cincinnati suburb, serving both medical and adult-use customers. The 3,825-square-foot Herbal Wellness Center is on a busy Route 4 retail corridor, adjacent to Jungle Jim's International Market, which is expected to support strong traffic.
The store is supplied by Vext's Tier One cultivation and manufacturing facilities in Jackson, Ohio. A seventh dual-use dispensary in Columbus is under construction and expected to open in Q4 2026, with an eighth site still under evaluation.
Vext Science (OTCQX: VEXTF) reported Q1 2026 revenue of $12.2 million, up 5.2% year-over-year. Gross profit more than doubled to $5.5 million (45.4% margin) and net loss narrowed 73.2% to $0.9 million. Adjusted EBITDA rose 73% sequentially to $3.6 million with a 29% margin.
Ohio revenue reached $8.2 million, up 34% year-over-year across five dispensaries. Operating cash flow was $1.6 million, with quarter-end cash of $5.5 million. The company is exiting Arizona cultivation while maintaining two dispensaries and light manufacturing, and reported a $10.6 million uncertain tax position.
Vext Science (OTCQX:VEXTF), a U.S.-based cannabis operator active in Arizona and Ohio, entered into an investor relations agreement with Zuanic & Associates starting May 15, 2026.
Zuanic will provide advisory, research and investor relations services for up to US$7,000 per month over a twelve-month term.
Vext (OTCQX:VEXTF) will release Q1 2026 financial results before market open on May 21, 2026. Management will host a conference call and webcast at 8:00 am ET the same day for investors to review and discuss the quarter.
Vext (OTCQX: VEXTF) reported fiscal 2025 revenue of $51.4M, up 43% year-over-year, with Adjusted EBITDA of $10.9M and operating cash flow of $11.7M (up 256% YoY). Q4 revenue was $13.7M with a $5.0M non-cash goodwill/intangible impairment in Columbus.
The company expanded Ohio retail to five locations, is pursuing the state cap of eight dispensaries by early 2027, and plans to exit Eloy cultivation in Arizona to sell the facility and redeploy capital toward Ohio growth. Prior-period financials were restated for inventory amortization, prepaid asset classification, and uncertain tax positions.